This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
FDA approves ribavirin for infant RS virus use in aerosol form
The FDA conditionally approves ribavirin for infants with respiratory syncytial virus, a move tied to labeling changes. Officials say the inhaled aerosol form may be impractical for AIDS patients, though doctors may prescribe off label for AIDS care once final approval occurs.
MENTIONED IN THIS ARTICLE
New York
Mexico
United States
Brad Stone
U.S. Food and Drug Administration
Stone
Caroline Breese Hall
University of Rochester Medical Center
Stephen Caiazza
Caiazza
ICN Pharmaceuticals
Costa Mesa
Calif
Kbavirin
Viratek
FDA
Michael Scolaro
St. Vincent Medical Center
Los Angeles